Navigation Links
Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial
Date:12/2/2008

thers with significantly more resources; market acceptance of our products and the size of our markets; changes in business strategy or development plans; changes in, or the failure to comply with, governmental regulations; and other factors referenced in our annual report, our Annual Information Form (AIF) (Form 40-F in the U.S.) and other filings with Canadian and United States securities regulatory authorities. Given these uncertainties, assumptions and risks, readers are cautioned not to place undue reliance on such forward-looking statements or information. We disclaim any obligation to update, or to publicly announce any revisions to, any such statements or information to reflect future results, events or developments, except as required by law.


'/>"/>
SOURCE Response Biomedical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nordic Naturals Offers Cod Liver Oil Solutions in Response to Recent Vitamin A and Vitamin D Controversy
2. FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections
3. Bayer HealthCare Donates Hundreds of Food Items to Community Food Bank of New Jersey in Response to Governors Plea to Help the States Population in Need
4. Zimbabwean Health Workers Call For Crisis Response
5. TV News Story on Canine Cancer Generates Dog Lover Response - No. 1 Health Issue for Americas 40 Million Dog-Owning Households
6. iMedExchange Responses to Financial Crisis
7. Response rates to antidepressants differ among English- and Spanish-speaking Hispanics
8. Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference
9. Response Biomedical Closes $5.1 Million Financing
10. A useful imaging modality for monitoring treatment response to hepatocellular carcinoma
11. Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Discover Health Through Awareness 2Discover Health Through Awareness 3TeamStaff Inc To Announce Third Quarter Results 54190 1TeamStaff Inc To Announce Third Quarter Results 54190 2TeamStaff Inc To Announce Third Quarter Results 54190 3Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 1Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 2Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 3Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 4Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 5Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 6Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 7Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 8Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 9Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 10Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 11Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 12Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 13ValueOptions 28R 29 Awards Coordination of Benefits and Overpayment Services Contract to HMS 54184 1ValueOptions 28R 29 Awards Coordination of Benefits and Overpayment Services Contract to HMS 54184 2